ARCA Biopharma Probability of Future Stock Price Finishing Over 10.18
ARCA Biopharma's future price is the expected price of ARCA Biopharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of ARCA Biopharma performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Please specify ARCA Biopharma's target price for which you would like ARCA Biopharma odds to be computed.
ARCA |
ARCA Biopharma Target Price Odds to finish over 10.18
The tendency of ARCA Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 10.18 or more in 90 days |
| 0.00 | 90 days | 10.18 | close to 99 |
Based on a normal probability distribution, the odds of ARCA Biopharma to move over $ 10.18 or more in 90 days from now is close to 99 (This ARCA Biopharma probability density function shows the probability of ARCA Stock to fall within a particular range of prices over 90 days) . Probability of ARCA Biopharma price to stay between its current price of $ 0.00 and $ 10.18 at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days ARCA Biopharma has a beta of 0.41. This suggests as returns on the market go up, ARCA Biopharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ARCA Biopharma will be expected to be much smaller as well. Additionally ARCA Biopharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. ARCA Biopharma Price Density |
| Price |
Predictive Modules for ARCA Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ARCA Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ARCA Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ARCA Biopharma is not an exception. The market had few large corrections towards the ARCA Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ARCA Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ARCA Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.79 | |
β | Beta against Dow Jones | 0.41 | |
σ | Overall volatility | 4.00 | |
Ir | Information ratio | -0.06 |
ARCA Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ARCA Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ARCA Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ARCA Biopharma is now traded under the symbol ORKA. Please update your portfolios or report it if you believe this is an error. Report It! | |
| ARCA Biopharma is not yet fully synchronised with the market data | |
| ARCA Biopharma has some characteristics of a very speculative penny stock | |
| ARCA Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (5.34 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ARCA Biopharma currently holds about 46.44 M in cash with (5.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies |
ARCA Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ARCA Stock often depends not only on the future outlook of the current and potential ARCA Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ARCA Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 14.4 M | |
| Cash And Short Term Investments | 37.4 M |
ARCA Biopharma Technical Analysis
ARCA Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. ARCA Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ARCA Biopharma. In general, you should focus on analyzing ARCA Stock price patterns and their correlations with different microeconomic environments and drivers.
ARCA Biopharma Predictive Forecast Models
ARCA Biopharma's time-series forecasting models is one of many ARCA Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ARCA Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ARCA Biopharma
Checking the ongoing alerts about ARCA Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ARCA Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ARCA Biopharma is now traded under the symbol ORKA. Please update your portfolios or report it if you believe this is an error. Report It! | |
| ARCA Biopharma is not yet fully synchronised with the market data | |
| ARCA Biopharma has some characteristics of a very speculative penny stock | |
| ARCA Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (5.34 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ARCA Biopharma currently holds about 46.44 M in cash with (5.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in ARCA Stock
If you are still planning to invest in ARCA Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ARCA Biopharma's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |